Focal lymphoid aggregates (nodules) in bone marrow biopsies: Differentiation between benign hyperplasia and malignant lymphoma - A practical guideline

Journal of Clinical Pathology

Volumn 52, Issue 4, 1999, Pages 294-300

  Thiele, J ^a   Zirbes, T K ^a   Kvasnicka, H M ^a   Fischer, R ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bone marrow; Lymphoid nodules; Reactive neoplastic lesions; Trephine biopsies

Indexed keywords

ARTICLE; BENIGN TUMOR; BONE MARROW BIOPSY; CANCER DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE HYPERPLASIA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

EID: 0032905269     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.4.294     Document Type: Article

References (40)

1. 1 Rywlin AM, Ortega RS, Dominguez CJ. Lymphoid nodules of bone marrow: normal and abnormal. Blood 1974;43:389-400.
2. 2 Bartl R, Frisch B, Burkhardt R, et al. Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol 1984;37:233-54.
3. 3 Navone R, Valpreda M, Pich A. Lymphoid nodules and nodular lymphoid hyperplasia in bone marrow biopsies. Acta Haematol 1985;74:19-22.
4. 4 Faulkner-Jones BE, Howie AJ, Boughton BJ, et al. Lymphoid aggregates in bone marrow: study of eventual outcome. J Clin Pathol 1988;41:768-75.
5. 5 McKenna RW, Hernandez JA. Bone marrow in malignant lymphuma. Hematol Oncol Clin North Am 1988;2:617-35.
6. 6 Salisbury JR, Deverell MH, Cookson MJ. Three-dimensional reconstruction of benign lymphoid aggregates in bone marrow trephines. J Pathol 1996;178:447-50.
7. 7 Manoharan A, Catovsky D, Clein P, et al. Simultaneous or spontaneous occurrence of lympho-and myeloproliferative disorders: a report of four cases. Br J Hacmatol 1981;48: 111-16.
8. 8 Cervantes F, Pereira A, Marti JM, et al. Bone marrow lymphoid nodules in myeloproliferative disorders: association with the non-myelosclerotic phases of idiopathic myelofibrosis and immunological significance. Br J Haematol 1988;70:279-82.
9. 9 Franco V, Florena AM, Aragona F, et al. Immunohistochemical evaluation of bone marrow lymphoid nodules in chronic myeloproliferative disorders. Virchows Arch A Pathol Anat 1991;419:261-6.
10. 10 Bartl R, Frisch B, Wilmanns W. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur J Haematol 1993;50:41-52.
11. 11 Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988;i:292-3.
12. 12 Schaefer HE. How to fix, decalcify and stain paraffinembedded bone marrow biopsies. In: Lennert K, Huebner K, eds. Pathology of the bone marrow. Stuttgart: Fischer, 1984:6-9.
13. 13 Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
14. 14 Erber WN. Human leucocyte differentiation antigens: review of the CD nomenclature. Pathology 1990;22:61-9.
15. 15 Thiele J, Arenz B, Klein H, et al. Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry. Virchows Arch A Pathol Anat 1988;412:553-62.
16. 16 Bartl R, Frisch B, Ketter G, et al. Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification, and staging. Br J Haematol 1982;51:511-30.
17. 17 Vykoupil KF, Georgii A. Non-Hodgkin's lymphomas in bone marrow: diagnosis according to Kiel classification and their growth patterns and relations to survival. In: Lennert K, Huebner K, eds. Pathology of the bone marrow. Stuttgart: Fischer, 1984:339-46.
18. 18 Foucar F, McKenna RW, Frizzera G, et al. Bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Cancer 1982;49:888-97.
19. 19 Bennett JM, Cain KC, Glick JH, et al. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the eastern cooperative oncology group experience. J Clin Oncol 1986;4:1462-9.
20. 20 Thaler J, Dietze O, Denz H, et al. Bone marrow diagnosis in lymphoproliferative disorders: comparison of results obtained from conventional histomorphology and immunohistology. Histopathology 1991;18:495-504.
21. 21 Lambertenghi-Deliliers G, Annaloro C, Soligo D, et al. Incidence and histological features of bone marrow involvement in malignant lymphomas. Ann Hematol 1992; 65:61-5.
22. 22 Schmid C, Isaacson PG. Bone marrow trephine biopsy in lymphoproliferative disease. J Clin Pathol 1992;45:745-50.
23. 23 Bartl R, Frisch B, Burkhardt R, et al. Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol 1982;51:345-60.
24. 24 Han T, Barcos M, Emrich L, et al. Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. J Clin Oncol 1984; 2:562-70.
25. 25 Rozman C, Montserrat E, Rodriguez-Fernández JM, et al. Bone marrow histologic pattern - the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984;64:642-8.
26. 26 Pangalis GA, Roussou PA, Kittas C, et al. B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients - experience from a single hematology unit. Cancer 1987;59:767-71.
27. 27 Montserrat E, Rozman C. Bone marrow biopsy in chronic lymphocytic leukemia: a review of its prognostic importance. Blood Cells 1987;12:315-26.
28. 28 Frisch B, Bartl R. Histologic classification and staging of chronic lymphocytic leukemia. A retrospective and prospective study of 503 cases. Acta Haematol 1988;79:140-52.
29. 29 Frisch B, Bartl R, Goebel FD. Bone marrow manifestations in the acquired immune deficiency syndrome (AIDS). A study of 40 patients and review of the literature. Hematol Rev 1989;3:177-86.
30. 30 Harris CF., Biggs JC, Concannon AJ, et al. Peripheral blood and bone marrow findings in patients with acquired immune deficiency syndrome. Pathology 1990;22:206-11.
31. 31 Karcher DS, Frost AR. The bone marrow in human immunodeficiency virus (HIV)-related disease. Am J Clin Pathol 1991;95:63-71.
32. 32 Thiele J, Langohr J, Skorupka M, et al. Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy) - a morphometric evaluation before and after therapy. Virchows Arch A Pathol Anat 1990;417:485-92.
33. 33 Kronland R, Grogan T, Spier C, et al. Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow. Hum Pathol 1985;16:1247-54.
34. 34 Pizzolo G, Chilosi M, Cetto GL, et al. Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders. Br J Haematol 1992;50:95-100.
35. 35 Pileri SA, Roncador G, Ceccarelli C, et al. Immunohistochemistry of bone marrow biopsy. Leukemia Lymphoma 1997; 26(suppl 1):69-75.
36. 36 Ben-Ezra JM, King BE, Harris AC, et al. Staining for bcl-2 protein helps to distinguish benign from malignant lymphoid aggregates in bone marrow biopsies. Mod Pathol 1994;7:560-64.
37. 37 Fakan F, Skálova A, Kuntscherová J. Expression of bcl-2 protein in distinguishing benign from malignant lymphoid aggregates in bone marrow biopsies. Gen Diagn Pathol 1995/96;141:359-63.
38. 38 Bartl R, Hansmann ML, Frisch B, et al. Comparative histology of malignant lymphomas in lymph node and bone marrow. Br J Haematol 1988;69:229-37.
39. 39 Conlan MG, Bast M, Armitage JO, et al. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. J Clin Oncol 1990;8:1163-72.
40. 40 Kluin PM, van Kricken JH, Kleiverda D, et al. Discordant morphologic characteristics of B-cell lymphomas in bone marrow and lymph node biopsies. Am J Clin Pathol 1990;94:59-66.